Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis-Reference-Cited by-同舟云学术

Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis

Published:2021-12-28 Issue: Volume: Page:
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatology Communications

Author:

Pose Elisa¹²³,Solà Elsa¹²³^ORCID,Lozano Juan J.³,Juanola Adrià¹²³,Sidorova Julia⁴,Zaccherini Giacomo⁵⁶,Wit Koos⁷^ORCID,Uschner Frank⁸,Tonon Marta⁹,Kazankov Konstantin¹⁰,Jiménez Cesar¹¹,Campion Daniela¹²,Napoleone Laura¹²³,Ma Ann T.¹²³^ORCID,Carol Marta¹²³,Morales‐Ruiz Manuel²³,Alessandria Carlo¹²,Beuers Ulrich⁷,Caraceni Paolo⁵⁶^ORCID,Francoz Claire¹³,Durand François¹³,Mookerjee Rajeshwar P.¹⁰,Trebicka Jonel⁸^ORCID,Vargas Victor³¹¹,Piano Salvatore⁹^ORCID,Watson Hugh¹⁴¹⁵,Abraldes Juan G.¹⁶,Kamath Patrick S.¹⁷,Davis Mark M.¹⁸¹⁹²⁰,Ginès Pere¹²³^ORCID,Schulz M.,Ferstl P.,Giovo I.,Roux O.,Simon‐Talero M.,Pérez‐Guasch M.,Rubio A.B.,Cervera M.,Martínez S.,Fabrellas N.,Pich J.,Vives A.,Avitabile E.,Graupera I.,Solé C.,Bassegoda O.,Gratacós‐Ginès J.,Joyera M.,Palacio E.,Aban M.,Lanzillotti T.,Nicolao G.,Chiappa M.T.,Esnault V.,Andrade R.,Pavesi M.,Korenjak M.,Farrés J.,Serra‐Burriel M.,Angeli P.,

Affiliation:

1. Liver Unit Hospital Clinic de Barcelona, School of Medicine and Health SciencesUniversity of Barcelona Barcelona Spain

2. Institut d’Investigacions Biomediques August Pi i Sunyer Barcelona Spain

3. Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas Barcelona Spain

4. Instituto de Tecnología del ConocimientoCampus de SomosaguasUniversidad Complutense de Madrid Pozuelo de Alarcon Spain

5. Department of Medical and Surgical Sciences University of Bologna Bologna Italy

6. Bologna University Hospital Authority St. Orsola‐Malpighi Polyclinic Bologna Italy

7. Department of Gastroenterology and Hepatology Academic Medical CenterUniversity of Amsterdam Amsterdam the Netherlands

8. Department of Internal Medicine Goethe University Frankfurt Frankfurt Germany

9. Unit of Internal Medicine and Hepatology Department of Medicine University of Padova Padova Italy

10. Institute for Liver and Digestive Health Division of Medicine Royal Free HospitalUniversity College London London United Kingdom

11. Liver Unit, Hospital Vall d'Hebron and Vall d'Hebron Research Unit Universitat Autònoma de Barcelona Barcelona Spain

12. Division of Gastroenterology and Hepatology Città della Salute e della Scienza HospitalUniversity of Turin Turin Italy

13. Hepatology and Liver Intensive Care Unit, Hospital Beaujon Assistance Publique–Hôpitaux de ParisClichyUniversity Paris Diderot Paris France

14. Evotec ID Virology, Lyon France

15. Department of Clinical Pharmacology Aarhus University Aarhus Denmark

16. Division of Gastroenterology, Liver Unit University of Alberta Edmonton AB Canada

17. Division of Gastroenterology and Hepatology Mayo Clinic Rochester MN USA

18. Institute for Immunity, Transplantation and Infection Stanford University Stanford CA USA

19. Department of Microbiology and Immunology Stanford University Stanford CA USA

20. Howard Hughes Medical Institute Stanford University Stanford CA USA

Funder

Horizon 2020 Framework Programme

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1881

Reference49 articles.

1. Compensated cirrhosis: Natural history and prognostic factors

2. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies

3. Liver cirrhosis

4. Acute-on-chronic liver failure: an update

5. Global burden of disease: acute‐on‐chronic liver failure, a systematic review and meta‐analysis;Mezzano G;Gut,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of non-invasive methods of assessment of steatosis and fibrosis in chronic diffuse liver diseases of various etiologies;GASTROENTEROLOGY;2023-06-22

2. Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC;Hepatology;2023-01-03

3. Metabolomics profiles in acute-on-chronic liver failure: Unveiling pathogenesis and predicting progression;Frontiers in Pharmacology;2022-08-19

4. The Role of Statins in Cirrhosis;Current Treatment Options in Gastroenterology;2022-07-07

5. Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failure;JHEP Reports;2022-06